Allspring Global Investments’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $99.3M | Sell |
5,967,504
-316,184
| -5% | -$5.26M | 0.17% | 151 |
|
|
2025
Q1 | $96.1M | Buy |
6,283,688
+5,186,592
| +473% | +$79.3M | 0.17% | 144 |
|
|
2024
Q4 | $23.4M | Buy |
1,097,096
+1,045,305
| +2,018% | +$22.3M | 0.04% | 490 |
|
|
2024
Q3 | $933K | Sell |
51,791
-10,619
| -17% | -$191K | ﹤0.01% | 1348 |
|
|
2024
Q2 | $1.01M | Buy |
62,410
+25,657
| +70% | +$417K | ﹤0.01% | 1335 |
|
|
2024
Q1 | $519K | Buy |
36,753
+7,763
| +27% | +$110K | ﹤0.01% | 1522 |
|
|
2023
Q4 | $303K | Buy |
28,990
+12,882
| +80% | +$134K | ﹤0.01% | 1606 |
|
|
2023
Q3 | $164K | Buy |
+16,108
| New | +$164K | ﹤0.01% | 1815 |
|